Total Payments
$5,401
2022 Payments
$38.44
Companies
31
Transactions
314
Medicare Patients
637
Medicare Billing
$123,320
Payment Breakdown by Category
Food & Beverage$5,342 (98.9%)
Education$58.50 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,342 | 313 | 98.9% |
| Education | $58.50 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,155 | 67 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $702.69 | 35 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $582.52 | 33 | $0 (2021) |
| Janssen Biotech, Inc. | $331.50 | 24 | $0 (2020) |
| Concordia Pharmaceuticals Inc. | $329.46 | 20 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $294.09 | 14 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $249.98 | 17 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $197.68 | 11 | $0 (2021) |
| Shionogi Inc | $193.70 | 9 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $136.47 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $38.44 | 2 | Olympus America Inc. ($24.91) |
| 2021 | $615.32 | 33 | AbbVie Inc. ($180.10) |
| 2020 | $637.55 | 38 | AbbVie Inc. ($201.46) |
| 2019 | $1,467 | 83 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($332.35) |
| 2018 | $1,254 | 78 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($272.57) |
| 2017 | $1,389 | 80 | Valeant Pharmaceuticals North America LLC ($294.09) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2022 | Olympus America Inc. | SINGLE USE GRASPING FORCEPS (Device), Single Use Electrosurgical Hemostatic Forceps | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Endotherapy | ||||||
| 01/11/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/21/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Neuroscience | ||||||
| 08/12/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/11/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Neuroscience | ||||||
| 08/05/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Antibiotic | ||||||
| 07/29/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/12/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Neuroscience | ||||||
| 07/08/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/14/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: Neuroscience | ||||||
| 06/11/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/10/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/07/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: GI COLON PREP | ||||||
| 05/28/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/10/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/05/2021 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Gastroenterology | ||||||
| 05/03/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/22/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.05 | General |
| 04/21/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/15/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Antibiotic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 264 | 340 | $152,250 | $54,558 |
| 2020 | 5 | 373 | 503 | $222,900 | $68,763 |
Total Patients
637
Total Services
843
Medicare Billing
$123,320
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 182 | $45,500 | $19,539 | 42.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 36 | 36 | $50,400 | $15,851 | 31.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 31 | 32 | $44,800 | $12,638 | 28.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 46 | 65 | $6,550 | $4,381 | 66.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 25 | $5,000 | $2,149 | 43.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 198 | 319 | $79,750 | $28,156 | 35.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 57 | 57 | $79,800 | $20,579 | 25.8% |
| 45380 | Biopsy of large bowel using an endoscope | Office | 2020 | 31 | 31 | $43,400 | $13,045 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 80 | $15,950 | $4,770 | 29.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,000 | $2,213 | 55.3% |
About Dr. Vincent Sottile, MD
Dr. Vincent Sottile, MD is a Gastroenterology healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790765493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Sottile, MD has received a total of $5,401 in payments from pharmaceutical and medical device companies, with $38.44 received in 2022. These payments were reported across 314 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,342).
As a Medicare-enrolled provider, Sottile has provided services to 637 Medicare beneficiaries, totaling 843 services with total Medicare billing of $123,320. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Staten Island, NY
- Active Since 01/19/2006
- Last Updated 05/15/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790765493
Products in Payments
- Humira (Biological) $500.08
- Entyvio (Biological) $488.06
- XIFAXAN (Drug) $406.39
- STELARA (Biological) $317.71
- Creon (Drug) $259.50
- TRULANCE (Drug) $237.24
- HUMIRA (Biological) $225.83
- LINZESS (Drug) $219.83
- Donnatal (Drug) $217.19
- UCERIS (Drug) $208.66
- DIFICID (Drug) $138.31
- ENTYVIO (Biological) $125.98
- Linzess (Drug) $123.67
- XIFAXANIBSD (Drug) $112.68
- DONNATAL (Drug) $112.27
- Symproic (Drug) $110.25
- ZEPATIER (Drug) $98.99
- XELJANZ (Drug) $98.35
- OCALIVA (Drug) $95.50
- Movantik (Drug) $90.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Staten Island
Dr. Sherif Farag, Md, MD
Gastroenterology — Payments: $160,829
Gastroenterology $160,829
Dr. Sherif Andrawes, Md, MD
Gastroenterology — Payments: $92,017
Gastroenterology $92,017
Deepak Vadada, Md, MD
Gastroenterology — Payments: $34,107
Gastroenterology $34,107
Daniel Megna, Md, MD
Gastroenterology — Payments: $14,432
Gastroenterology $14,432
Anu Sampat, Md, MD
Gastroenterology — Payments: $12,199
Gastroenterology $12,199
Richard Fazio, M.d, M.D
Gastroenterology — Payments: $11,738
Gastroenterology $11,738